Dr. Harold Joseph Boutte Jr., MD

Dr. Boutte practices at Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare.

Dr. Boutte's NPI, 1487911038, was assigned on April 20, 2012. Dr. Boutte graduated from Duke University School of Medicine in 2012. Dr. Boutte holds Illinois license 036145207.

Dr. Boutte's primary practice is Northwestern Memorial Hospital, at 251 E Huron St, Chicago, IL 60611 in Cook County. The practice phone is (312) 926-2000.

Dr. Boutte's primary practice is Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare. Dr. Boutte is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Boutte to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boutte practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Boutte's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Boutte is licensed in Illinois.

CMS data shows 412 Medicare services from Dr. Boutte across 8 procedure codes in 2024, for 223 Medicare patients. Medicare paid $39,493 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 223 Medicare patients who saw Dr. Boutte in 2024. The largest group is 65 to 74, with 114 patients. 73% of them have high cholesterol, and 70% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boutte's median patient age at 64, with 54% women.

In 2024, Dr. Boutte wrote 827 Medicare Part D claims for 158 patients. 69% of them were for generic drugs. CMS names the drug for 673 of them, across 22 drugs with 11 or more claims each, at $524,709 in total drug cost. In 2023, CMS named 476 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Boutte for performance year 2024, reported through an alternative payment model (APM). Dr. Boutte accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boutte as offering telehealth. CMS counts 28 procedures of colonoscopy by Dr. Boutte, more than 53% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Boutte, published from 2020 to 2021. Dr. Boutte's most frequent co-authors are Teminioluwa Ayotunde Ajayi, MD, Katherine Schuver Garman, MD and Marc Stephen Levin, MD.

CMS Open Payments shows 23 general payments to Dr. Boutte from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Abbvie Inc. paid the most, $8,875.

Dr. Boutte graduated from Duke University School of Medicine in 2012.